KS

Kalyan Sunil Kharde

Active Director Designated Partner DIN 11344533
DIN 11344533 First appointment Oct 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalyan Sunil Kharde

Data last updated:

Kalyan Sunil Kharde is a Designated Partner at Dwarakesh Nepharolife Llp (since 2025).

DIN 11344533
Primary Designation Designated Partner
First Appointment 16 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Oct 20252025Active

Board colleagues of Kalyan Sunil Kharde

NameDINCompanyDesignation
Shubham Sunil Kharde11344534Dwarakesh Nepharolife LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dwarakesh Nepharolife Llp
Premium access

Shareholding and investment profile for Kalyan Sunil Kharde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalyan Sunil Kharde

Kalyan Sunil Kharde currently holds 1 directorship: Dwarakesh Nepharolife Llp (Designated Partner, since 16 Oct 2025).

Kalyan Sunil Kharde was first appointed on 16 Oct 2025 as Designated Partner at Dwarakesh Nepharolife Llp.

The current boards of Kalyan Sunil Kharde's companies include Shubham Sunil Kharde (Dwarakesh Nepharolife Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available